Delivery Order SPE2DB24D1107-SPE2DB25FZFG3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $12,590.49. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,494.17 by the Defense Logistics Agency on July 31, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a 0.5 ml dosage. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded through open competition. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order valued at $19,098.09 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors on December 19, 2025. This is a firm fixed-price delivery order with an ultimate completion date of December 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,678.64 for Trulicity 1.5 mg/0.5 ml pen injectors on June 27, 2025, with completion expected by June 30, 2025. This is a firm fixed-price, non-set-aside competitive award to be performed at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- The Defense Logistics Agency awarded a delivery order valued at $5,050.63 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on August 18, 2025, with completion targeted for August 19, 2025. The contract employs firm fixed pricing under a non-competitive delivery order structure and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,007.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026. The place of performance is listed as AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $3,747.04 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml) on December 19, 2025, with an ultimate completion date of December 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $2,616.66 with a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of December 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's critical role as a pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,076.73 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to support federal medical procurement needs. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its...
- The Defense Logistics Agency awarded a $1,865.83 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen injectors on May 6, 2025, with completion scheduled for May 7, 2025. This firm fixed-price delivery order is non-set-aside and represents a continuation of pharmaceutical supply under AmerisourceBergen's existing contract vehicle with DLA. The product will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB25FZFG3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors on May 12, 2025. This is a firm fixed price, non-set-aside contract with a completion date of May 13, 2025, and performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order falls under AmerisourceBergen's broader $999,999,999.00 IDC with the Defense Logistics Agency, designated as SPE2DX and extending through December 2026. The parent contract serves as a comprehensive pharmaceutical supply vehicle enabling AmerisourceBergen to deliver a wide range of medications, medical supplies, and specialized healthcare commodities to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to meet federal procurement requirements through open competition, supplying critical medications including diabetes treatments, neurological drugs, pain management pharmaceuticals, and other essential medical products to the Defense Health Agency and related military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 5/12/25 |